**Company Profile: Johnson & Johnson**

Johnson & Johnson (JNJ), a prominent player in the pharmaceutical industry, ranks 42nd in the esteemed Fortune 2024 list. The company, founded over a century ago, operates under the leadership of CEO Joaquin Duato. As a testament to its enduring success, Johnson & Johnson boasts a vast workforce of 131,900 employees across the globe.

Headquartered in New Brunswick, New Jersey, the U.S.-based company has consistently demonstrated its proficiency in the healthcare sector. With a market capitalization of $381,203.6 million as of March 28, 2024, Johnson & Johnson showcases an impressive market presence. This value has seen a revision to $359,173.0 million as of July 15, 2024.

In terms of revenue, Johnson & Johnson reported $95,195.0 million for the year, indicating a modest growth of 0.3% from the previous year. This achievement highlights the company's ability to maintain its revenue stream in a competitive market. Notably, Johnson & Johnson's profits saw a substantial increase of 95.9%, amounting to $35,153.0 million. This significant growth underscores the company's effective strategies and operational efficiency.

Johnson & Johnson's total assets stand at $167,558.0 million, further solidifying its position as a major player in the pharmaceutical industry. The company's inclusion in the Global 500 and recognition as one of the World's Most Admired Companies attests to its exemplary performance and reputation.

With a history of stability, Johnson & Johnson has been a part of the Fortune 500 list for an extended period, although its ranking has experienced a slight decline of two positions in the current year. Despite this, the company's commitment to innovation and growth remains unwavering, as evident from its continued presence in the list.

As a publicly traded company, Johnson & Johnson operates with transparency, and its financial performance is closely monitored by investors. The company's market value, as of the updated date of August 5, 2024, reflects its ongoing adaptation to the dynamic market landscape.

In conclusion, Johnson & Johnson's remarkable performance in the pharmaceutical industry, coupled with its significant market presence and growth in profits, solidifies its position as a leader in the healthcare sector. As the company continues to evolve, its dedication to innovation and excellence is expected to drive its future success.